SLC2A9 - A fructose transporter identified as a novel uric acid transporter

Nephrology Dialysis Transplantation

Volumn 23, Issue 9, 2008, Pages 2746-2749

  Le, MyPhuong T ^a,c   Shafiu, Mohamed ^b   Mu, Wei ^b   Johnson, Richard J ^a  

^a UNIVERSITY OF FLORIDA   (United States)

^b UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Fructose transporter; GLUT9; SLC2A9; Uric acid transporter

Indexed keywords

CARRIER PROTEIN; FRUCTOSE TRANSPORTER; ORGANIC ANION TRANSPORTER 1; ORGANIC ANION TRANSPORTER 3; PROTEIN SLC2A9; UNCLASSIFIED DRUG; URIC ACID TRANSPORTER;

5' UNTRANSLATED REGION; GENE; GENE MAPPING; GENETIC VARIABILITY; HUMAN; INTRON; KIDNEY TUBULE ABSORPTION; NOTE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SLC2A9 GENE; URIC ACID BLOOD LEVEL; URIC ACID URINE LEVEL; URINARY EXCRETION;

ANIMALS; FEMALE; FRUCTOSE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; GOUT; HOMEOSTASIS; HUMANS; HYPERURICEMIA; KIDNEY TUBULES, PROXIMAL; MALE; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS; SEX FACTORS; URIC ACID;

EID: 57749117336     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfn349     Document Type: Note

References (25)

1. Nath SD, Voruganti VS, Arar NH et al. Genome scan for determinants of serum uric acid variability. J Am Soc Nephrol 2007; 18: 3156-3163
2. Yang Q, Guo CY, Cupples LA et al. Genome-wide search for genes affecting serum uric acid levels: the Framingham Heart study. Metabolism 2005; 54: 1435-1441
3. Terkeltaub R, Bushinsky DA, Becker MA. Recent developments in our understanding of the renal basis of hyperuricemia and the development of novel antihyperuricemic therapeutics. Arthritis Res Ther 2006; 8(Suppl 1): S4
4. Mount DB, Kwon CY, Zandi-Nejad K. Renal urate transport. Rheum Dis Clin North Am 2006; 32: 313-331, vi
5. Anzai N, Kanai Y, Endou H. New insights into renal transport of urate. Curr Opin Rheumatol 2007; 19: 151-157
6. Graessler J, Graessler A, Unger S et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum 2006; 54: 292-300
7. Vazquez-Mellado J, Jimenez-Vaca AL, Cuevas-Covarrubias S et al. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology (Oxford) 2007; 46: 215-219
8. Ichida K, Hosoyamada M, Hisatome I et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J Am Soc Nephrol 2004; 15: 164-173
9. Li S, Sanna S, Maschio A et al. The GLUT9 gene is associated with serum uric acid levels in sardinia and chianti cohorts. PLoS Genet 2007; 3: e194
10. Brandstätter A, Kiechl S, Kollerits B et al. The gender-specific association of the putative fructose transporter SLC2A9 variants with uric acid levels is modified by BMI. Diabetes Care 2008; May 16 [Epub ahead of print].
11. Wallace C, Newhouse SJ, Braund P et al. Genome-wide association study identifies genes for biomarkers of cardiovascular disease: serum urate and dyslipidemia. Am J Hum Genet 2008; 82: 139-149
12. Vitart V, Rudan I, Hayward C et al. SLC2A9 is a newly identified urate transporter influencing serum urate concentration, urate excretion and gout. Nat Genet 2008; 40: 437-442
13. Doring A, Gieger C, Mehta D et al. SLC2A9 influences uric acid concentrations with pronounced sex-specific effects. Nat Genet 2008; 40: 430-436
14. Augustin R, Carayannopoulos MO, Dowd LO et al. Identification and characterization of human glucose transporter-like protein-9 (GLUT9): alternative splicing alters trafficking. J Biol Chem 2004; 279: 16229-16236
15. Johnson RJ, Titte S, Cade JR et al. Uric acid, evolution and primitive cultures. Semin Nephrol 2005; 25: 3-8
16. Conen D, Wietlisbach V, Bovet P et al. Prevalence of hyperuricemia and relation of serum uric acid with cardiovascular risk factors in a developing country. BMC Public Health 2004; 4: 9
17. Klein BE, Klein R, Lee KE. Components of the metabolic syndrome and risk of cardiovascular disease and diabetes in beaver dam. Diabetes Care 2002; 25: 1790-1794
18. Bos MJ, Koudstaal PJ, Hofman A et al. Uric acid is a risk factor for myocardial infarction and stroke: the Rotterdam study. Stroke 2006; 37: 1503-1507
19. Dehghan A, van Hoek M, Sijbrands EJ et al. High serum uric acid as a novel risk factor for type 2 diabetes. Diabetes Care 2008; 31: 361-362
20. Rosolowsky ET, Ficociello LH, Maselli NJ et al. High-normal serum uric acid is associated with impaired glomerular filtration rate in nonproteinuric patients with type 1 diabetes. Clin J Am Soc Nephrol 2008; 3: 706-713
21. Weiner DE, Tighiouart H, Elsayed EF et al. Uric acid and incident kidney disease in the community. J Am Soc Nephrol 2008.
22. Chonchol M, Shlipak MG, Katz R et al. Relationship of uric acid with progression of kidney disease. Am J Kidney Dis 2007; 50: 239-247
23. Nakagawa T, Hu H, Zharikov S et al. A causal role for uric acid in fructose-induced metabolic syndrome. Am J Physiol Renal Physiol 2006; 290: F625-F631
24. Kang DH, Park SK, Lee IK et al. Uric acid-induced C-reactive protein expression: implication on cell proliferation and nitric oxide production of human vascular cells. J Am Soc Nephrol 2005; 16: 3553-3562
25. Phay JE, Hussain HB, Moley JF. Cloning and expression analysis of a novel member of the facilitative glucose transporter family, SLC2A9 (GLUT9). Genomics 2000; 66: 217-220